Nagara Foundation halts gurdwara renovation work in Pakistan
Darpan News Desk IANS, 20 Jan, 2022 12:05 PM
New Delhi, Jan 20 (IANS) US-based Ranjit Nagara Foundation, which was overseeing the 'karsewa' (renovation/construction) of Gurdwara Chowa Sahib in Jhelum, Pakistan and other local gurdwaras, has notified that they has stopped the construction activities due to non-compliance of ETPB/PSGPC in providing them bills and expenditure details of the works carried out till date.
Satpreet Singh, Director of Ranjit Nagara Foundation, revealed that as per US rules, their foundation has to provide documentation of their expenditure to Internal Revenue Service, Department of Justice, annually which is further updated on the department's site for public or on before May 15, but the Evacuee Trust Property Board (ETPB) office has not provided the requisite documents till date. Thus, the NGO has to put its activities on hold.
Misappropriation of gurdwara funds by ETPB/PSGPC (Pakistan Sikh Gurdwara Parbandhak Committee) officials had been reported in the past as well.
The Nagara Foundation is largely funded by the Sikh diaspora with resources being further transferred to Pakistan
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced" among younger people who are less likely to become seriously ill with COVID-19
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.
